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ABSTRACT
OBJECTIVES
To estimate small for gestational age birth prevalence
and attributable neonatal mortality in low and middle
income countries with the INTERGROWTH-21st birth
weight standard.
DESIGN
Secondary analysis of data from the Child Health
Epidemiology Reference Group (CHERG), including
14 birth cohorts with gestational age, birth weight,
and neonatal follow-up. Small for gestational
age was defined as infants weighing less than
the 10th centile birth weight for gestational age
and sex with the multiethnic, INTERGROWTH-21st
birth weight standard. Prevalence of small for
gestational age and neonatal mortality risk ratios
were calculated and pooled among these datasets
at the regional level. With available national level
data, prevalence of small for gestational age and
population attributable fractions of neonatal mortality
attributable to small for gestational age were
estimated.

What is already known on this topic
Infants born small for gestational age are at risk for neonatal mortality
Small for gestational age is highly prevalent in low and middle income countries,
particularly in South Asia
Prior global estimates of small for gestational age have used the US 1991 live
birth data as the birth weight reference

What this study adds
An estimated 23.3 million infants (uncertainty range 17.6 million to 31.9
million; 19.3% of live births) were born small for gestational age in low and
middle income countries in 2012, with the INTERGROWTH-21st standard, the first
international, multiethnic birth weight standard, as reference
In low and middle income countries in 2012, 606 500 (21.9%) (495 000 to
773 000) neonatal deaths were attributable to small for gestational age
The highest burden was in South Asia, where the prevalence of small for
gestational age was the highest (34%) and the population attributable fraction of
attributable neonatal deaths was 26%
the bmj | BMJ 2017;358:j3677 | doi: 10.1136/bmj.j3677

SETTING
CHERG birth cohorts from 14 population based sites in
low and middle income countries.
MAIN OUTCOME MEASURES
In low and middle income countries in the year 2012,
the number and proportion of infants born small for
gestational age; number and proportion of neonatal
deaths attributable to small for gestational age; the
number and proportion of neonatal deaths that could
be prevented by reducing the prevalence of small for
gestational age to 10%.
RESULTS
In 2012, an estimated 23.3 million infants
(uncertainty range 17.6 to 31.9; 19.3% of live births)
were born small for gestational age in low and middle
income countries. Among these, 11.2 million (0.8 to
15.8) were term and not low birth weight (≥2500 g),
10.7 million (7.6 to 15.0) were term and low birth
weight (<2500 g) and 1.5 million (0.9 to 2.6) were
preterm. In low and middle income countries, an
estimated 606 500 (495 000 to 773 000) neonatal
deaths were attributable to infants born small for
gestational age, 21.9% of all neonatal deaths.
The largest burden was in South Asia, where the
prevalence was the highest (34%); about 26% of
neonatal deaths were attributable to infants born
small for gestational age. Reduction of the prevalence
of small for gestational age from 19.3% to 10.0% in
these countries could reduce neonatal deaths by 9.2%
(254 600 neonatal deaths; 164 800 to 449 700).
CONCLUSIONS
In low and middle income countries, about one in
five infants are born small for gestational age, and
one in four neonatal deaths are among such infants.
Increased efforts are required to improve the quality
of care for and survival of these high risk infants in low
and middle income countries

Introduction
Neonatal conditions are responsible for an increasing
proportion of deaths of children aged under 5 and
are a key focus of the post-2015 development agenda
1
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and the Every Newborn Action Plan.1 2 Preterm birth,
intrapartum related events, and neonatal infections
are the main direct causes of neonatal mortality.3
Other risk factors for mortality, however, such as
intrauterine growth restriction, are not classified as
underlying or immediate causes of death according
to ICD (international classification of diseases) rules.4
To most effectively target interventions to accelerate
reductions in neonatal mortality, it is critical to
quantify the attributable burden of mortality from
major neonatal risk factors that are not classified as
underlying or direct causes of death.
Infants born small for gestational age are defined
by the WHO Expert Committee5 and the American
College of Obstetrics and Gynecology6 as those
weighing below the 10th centile of birth weight by
sex for a specific completed gestational age of a given
reference population. It is commonly used as a proxy
for intrauterine growth restriction and, in settings
with a high prevalence of small for gestational age, is
more likely to be because of fetal intrauterine growth
restriction.7
Infants born small for gestational age carry a
considerably higher risk of mortality and morbidity
in the neonatal period and beyond. They are more
likely to have neonatal infections, perinatal respiratory
depression, jaundice, polycythemia, hypoglycemia,
poor feeding, and hypothermia. These morbidities
in turn place them at higher risk of death. In a
pooled analysis by the Child Health Epidemiology
Reference Group (CHERG), small for gestational age
was associated with increased risk of neonatal and
postneonatal mortality (risk ratio 1.83 (95% confidence
interval 1.34 to 2.50) for neonatal mortality; 1.90 (1.32
to 2.73) for postneonatal infant mortality) compared
with infants born at an appropriate size for gestational
age (≥10% birth weight for gestational age). The risk
was even higher among those born both preterm
and small for gestational age.8 Infants born small for
gestational age also have an increased risk of delayed
neurodevelopment and poor linear growth,9 with
those born term and preterm being 2.4 and 4.5 times,
respectively, more likely to be stunted in childhood
than term babies infants born appropriate size for
gestational age.10 Modifiable risk factors for small for
gestational age include poor maternal nutrition,11
maternal infections and other morbidities,12 young
maternal age,13 and short birth spacing.14 Intrauterine
programming and genetic modulation have also been
postulated as mechanisms resulting in small for
gestational age and increased risk of morbidity later in
life, predisposing those infants to higher risk of insulin
resistance, obesity, dyslipidaemia, and hypertension
in adulthood.15 16
Epidemiologic estimates of small for gestational age
vary substantially based on the reference population.17
The use of a single universal growth standard versus
local/national ethnic specific growth references is still
heavily debated.18 While genetic potential for growth
might differ across populations,19 20 this contribution
is believed by some to play a smaller role in low and
2

middle income countries on infant size at birth,
compared with the impact of maternal undernutrition
and pregnancy morbidity.5 As part of the CHERG, we
investigated the global burden of infants born small for
gestational age, the contribution of pregnancy risks,
and the potential impact of preventive interventions to
deal with risk factors to optimize fetal growth globally.
The INTERGROWTH-21st project21 (henceforth referred
to as Intergrowth) established the first international,
multiethnic standard including well dated pregnancies
from eight geographically defined populations, and
enables a common single standard to describe optimal
and aspirational fetal growth around the world.21 The
Intergrowth study found that among healthy pregnant
women with adequate nutrition, fetal growth was
comparable across different populations around the
world.22 Therefore, Intergrowth was chosen as the
standard for this analysis in a prescriptive sense, to
describe the global burden of suboptimal fetal growth.
Choice of unselected, local, national population
references would simply describe fetal growth with
current rates of exposure to undernutrition and
pregnancy morbidities in low and middle income
countries, and would not allow us to target the
optimization of fetal growth globally from a population
health perspective.
The population attributable fraction reflects the
burden of disease attributable to a causal risk factor
if it were reduced from the current exposure level to
a theoretical minimum counterfactual distribution.
This allows the estimation of the potential reduction in
mortality if the exposures were eliminated or, in other
words, the attribution of indirect deaths caused by
given risk factors. We estimated the number of infants
born small for gestational age in low and middle income
countries in 2012 using the new Intergrowth standard,
the number of neonatal deaths attributable to being
small for gestational age in these countries, and the
number of neonatal deaths that could be prevented by
reducing the prevalence of small for gestational age to
a theoretical minimum level of 10% in these countries.
We also compared our results to previously published
estimates of prevalence of small for gestational aged
derived from a US birth weight reference.23

Methods
We have built on prior analyses of the CHERG on
the burden and risk of small for gestational age and
preterm birth in low and middle income countries.82425
An investigator group (CHERG SGA-Preterm Birth
Working Group) was established in 2009 to conduct
a set of analyses related to small for gestational age
and preterm birth. To identify datasets to include in
the analyses, we reviewed Medline, WHO regional
databases (African Index Medicus, LILAS, EMRO),
manuscript bibliographies, and grey literature to
identify cohorts from low and middle income countries
with information on gestational age and birth weight
and that systematically recorded vital status until 28
days of life. We included datasets that were population
based, representing most deliveries from certain
doi: 10.1136/bmj.j3677 | BMJ 2017;358:j3677 | the bmj
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geographic or catchment areas, whether home or
facility based. We excluded datasets with more than
25% missing data on birth weight, gestational age,
or neonatal follow-up; measured weight only after
72 hours of life; did not have systematic follow-up of
vital status in the first month of life; or had imprecise
gestational age data (determined in whole months
or deemed “inaccurate” by study investigators). Full
details on the literature review process and selection
of datasets have been previously published by our
research group.8 Principal investigators were requested
to either individually conduct analyses or to share their
data with the working group. We included 14 birth
cohorts in this analysis.26-39 The original studies were
from prospective studies, including longitudinal birth
cohorts (n=4) and pregnancy/neonatal intervention
trials (n=10). The original datasets and study
descriptions are shown in appendix 1. Most datasets
were from 2000 onwards, with three studies from
the 1990s. This analysis excludes datasets used in
previous CHERG analyses that were from before 1990
or were not directly available to the analysts for this
study.8
In previously published analyses, we estimated the
prevalence of small for gestational age and preterm
birth in low and middle income countries for the year
2010, using the US 1991 birth population as a reference
(US National Center for Health Statistics, n=3 808 689
live births in 1991)25 and the associations of small for
gestational age (defined using this US reference) and
preterm birth with both neonatal and postneonatal
infant mortality, respectively.8 In the current analyses,
we estimate the numbers of small for gestational age
births and neonatal deaths attributable to this in
low and middle income countries in 2012 using the
international Intergrowth birth weight standard to
define small for gestational age.

Exposure definitions
Small for gestational age was defined as a birth weight
less than the 10th centile for a specific completed
gestational age by sex, using the Intergrowth
standard.21 40 The Intergrowth cutoffs were taken
from two publications, the first for gestational age
≥33 weeks21 and the second for <33 completed weeks
of gestation.40 In the CHERG cohorts, gestational age
was estimated with ultrasonography or best obstetric
estimate including ultrasonography in six studies,
date of last menstrual period alone for five studies,
postnatal clinical exam (Ballard and Capurro) for two
studies, and a combination in one study (see appendix
1 for more details). We also compared these results
with small for gestational age defined by the 1991 US
national population reference, which was used in the
original CHERG analysis.23 Preterm birth was defined
as gestational age of <37 completed weeks. Low
birth weight was defined as birth weight of <2500 g.
We created four mutually exclusive exposures: term
appropriate for gestational age (as reference), term
small for gestational age, preterm appropriate for
gestational age, and preterm small for gestational
the bmj | BMJ 2017;358:j3677 | doi: 10.1136/bmj.j3677
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Fig 1 | Combinations of exposure categories of
preterm birth, small for gestational age (SGA), and
low birth weight (LBW, <2500 g). AGA=appropriate for
gestational age

age (fig 1). Term small for gestational age was further
separated into low birth weight and not low birth
weight to differentiate the mortality burden associated
with smaller and larger term small for gestational age
infants.

Population distribution of small for gestational age
and preterm birth
CHERG previously estimated national and regional
prevalences of preterm birth24 and small for
gestational age for 201025 and 201241 using the
US 1991 population birth weight reference.23 To
estimate prevalence of small for gestational age
with the Intergrowth standard,21 we calculated the
percentage change of term and preterm small for
gestational age births in the 14 CHERG datasets,
comparing the US population reference with the
Intergrowth standard. We performed meta-analysis
using random effects to pool the percentage change
at the regional level (Asia, Africa, Americas) and
multiplied the region specific adjustment factor by
the previously estimated national level prevalences
of small for gestational age from 2012 (see appendix
2).42 We performed a similar process to calculate the
proportion of term small for gestational age infants
with low birth weight.
Risk ratios for neonatal mortality
Mortality was analyzed in the neonatal (birth-28 days
of life) period. For each dataset, we calculated risk
ratios for neonatal mortality (death within first 28 days
of life) for preterm birth and small for gestational age,
classified using the US 1991 reference and Intergrowth
standard.8 We pooled risk ratios for neonatal mortality
for categories of small for gestational age separately
for each reference/standard, at the regional level,
with random effects meta-analysis to calculate
DerSimonian-Laird pooled risk ratios and 95%
confidence intervals (see appendix 3).
Neonatal deaths attributable to small for
gestational age birth
We used neonatal mortality rates from the Inter-Agency
Group for Child Mortality Estimation43 and live births
from the UN Population Division44 for the year 2012.
3
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n

PAF =

and then aggregated by UN-Millennium Development
Goal regions for 138 low and middle income countries.

Σ i=1 Pi*RRi – Σ i=1 P'i*RRi
n
Σ i=1 Pi*RRi
n

Fig 2 | Equation for population attributable fraction (PAF).
Pi=proportion of population at exposure level i, current
exposure; P’i = proportion of population at exposure
level i, counterfactual or ideal level of exposure; RR= risk
ratio at exposure level i; n=number of exposure levels

Population attributable fraction, the “proportion
of cases for an outcome of interest that can be
attributed to a given risk factor,” is defined as the
(incidence rate in population−incidence rate in
unexposed)/incidence rate in the total population.45
In this paper, we estimated the neonatal deaths that
would result if the causally related risk factor (in this
case, small for gestational age) was reduced from
its current exposure level to a theoretical minimum
counterfactual distribution. Using established
methods of comparative risk assessment46 used for
the global burden of disease,47 we estimated the total
number of neonatal deaths that were attributable to
small for gestational age, as well as the number of such
deaths that would be prevented if the prevalence of
small for gestational age was reduced to a theoretical
minimum level of 10% in all low and middle income
countries, the distribution expected among low risk
mothers, similar to the Intergrowth population. For
the co-occurrence of preterm and small for gestational
age, the theoretical minimum risk level of mortality
was that of preterm appropriate for gestational age
infants to attribute the deaths related only to small for
gestational age. The population attributable fraction
for multiple category exposures can be estimated by
the equation for potential impact fraction (fig 2).45 48 49
We calculated population attributable fractions and
number of neonatal deaths averted at the national level

Population attributable fraction uncertainty
estimates
Methods to estimate uncertainty ranges have been
developed by the CHERG by using a bootstrap
approach as opposed to jackknife procedures to allow
more plausible uncertainty ranges.3 These methods are
described in detail in appendix 4.
Patient involvement
This study was a secondary data analysis of existing
datasets, which did not involve new direct contact with
patients. For all parts of these secondary data analyses,
patients, caregivers, and lay people were not involved in
the development of the research question, study design,
or outcome measures, nor the interpretation or writing up
of the results. Some of the original studies contributing
to this analysis included recruitment of participants by
lay community health workers. Data from this study will
be published and made publicly available. Investigators
might share the results with local ministries of health,
patients (including original study participants), and
relevant medical organizations in the respective countries
where the original studies were conducted.
Results
Small for gestational age live births in low and
middle income countries in 2012
Table 1 and figure 3 show the estimated numbers and
prevalence of small for gestational age among live
births for the year 2012, defined by the Intergrowth
standard. National level estimates are available in
appendix 5. The regional numbers are compared with
estimates using the US 1991 population reference in
appendix 6. In low and middle income countries, 23.3
million infants were born small for gestational age as

Table 1 | Numbers of 1000s of infants born small for gestational age (SGA) in 2012 with INTERGROWTH-21st birth weight standard in low and middle
income countries in regions covered by UN Millennium Development Goals
No of live
births (1000s)

No (UR*) of term SGA (1000s)
Not low birth weight

Low birth weight†

Caucasus/Central Asia

1774.3

87.0 (49.2 to 148.6)

Eastern Asia

19 097.2

Latin America/Caribbean

10 833.3

Northern Africa

3989.8

Oceania
South East Asia

266.4
9691.1

South Asia

36 625.8

Sub-Saharan Africa

33 727.5

Western Asia

4 844.9

Total

120 850.2

387.4 (170.4 to
788.5)
516.3 (406.5 to
1157.1)
120.9 (59.8 to
233.0)
20.0 (12.1 to 31.6)
941.7 (587.6 to
1448.6)
5908.5 (3849.1 to
8672.5)
2829.5 (1522.8 to
5105.4)
346.0 (213.3 to
538.3)
11 157.4 (8195.4 to
15 798.3)

89.1 (50.8 to
152.0)
396.8 (180.0 to
799.2)
303.2 (241.1 to
687.5)
102.6 (49.8 to
200.6)
20.4 (12.9 to 32.4)
964.6 (609.8 to
1499.1)
6052.1 (3974.6 to
8954.2)
2400.6 (1253.1 to
4297.7)
354.4 (224.7 to
558.5)
10 683.9 (7616.9 to
15 017.0)

No (UR*) of preterm
SGA (1000s

Total No (UR*) of SGA
(1000s)

% prevalence (UR*)
SGA

19.4 (9.4 to 41.6)

195.5 (121.1 to
314.1)
949.5 (536.7 to
1735.4)
930.3 (793.2 to
2019.5)
248.2 (138.9 to
455.7)
42.7 (28.1 to 66.0)
2089.9 (1403.2 to
3157.7)
12 537.7 (8651.8 to
18 100.0)
5575.2 (3276.3 to
9277.2)
756.6 (504.6 to
1154.3)
23 325.6 (17 599.3
to 31 914.8)

11.0 (6.2 to 19.3)

165.4 (82.6 to
320.1)
110.8 (83.3 to
243.5)
24.6 (10.3 to 53.7)
2.3 (1.0 to 6.3)
183.5 (88.0 to
386.4)
577.1 (291.6 to
1162.3)
345.0 (158.9 to
716.8)
56.2 (28.2 to 118.2)
1484.3 (902.2 to
2628.7)

5.0 (2.4 to 10.4)
8.6 (6.7 to 19.3)
6.2 (3.0 to 12.2)
16.0 (9.8 to 26.4)
21.6 (14.2 to 37.7)
34.2 (22.2 to 51.3)
16.5 (8.7 to 25.1)
15.6 (9.6 to 25.1)
19.3 (11.9 to 32.1)

*Uncertainty range (UR) derived with bootstrap approach (see appendix 4).
†≤2500 g.
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Fig 3 | Prevalence of infants born small for gestational
age (SGA) among live births in low and middle income
countries in 2012, by UN-MDG region. LBW=low birth
weight (<2500 g)

defined by the Intergrowth standard, with a prevalence
of 19.3%. The highest number and prevalence of such
births was in South Asia, at 12.5 million (34.2%)
infants. Most (62.7%) small for gestational age births
occurred in South or South East Asia. An estimated 5.6
million infants born in sub-Saharan Africa were small
for gestational age (prevalence 16.5%).
The total number of estimated small for gestational
age births was 27% lower when we used the Intergrowth
standard compared with the US population reference
(appendix 6). The largest absolute difference was in
the number of term small for gestational age infants
who weighed above 2500 g (18.8 million by US
1991 reference compared with 11.2 million with the
Intergrowth standard, 41% reduction). The greatest
relative reduction was among the preterm infants
(47% lower with Intergrowth).

Neonatal deaths attributable to small for
gestational age in 2012
An estimated 606 500 neonatal deaths (21.9% of
neonatal deaths) in low and middle income countries

were attributable to being born small for gestational
age in 2012, as defined with the Intergrowth standard
(table 2, fig 4). In total, 410 600 were among term
small for gestational age infants, the majority weighing
<2500 g, and an estimated 195 900 neonatal deaths
among preterm small for gestational age infants. The
largest number of neonatal deaths attributable to
small for gestational age was in South Asia, where the
prevalence of small for gestational age was highest
(at 34%) and 26% of neonatal deaths were attributed
to this risk factor. About half of the neonatal deaths
attributable to small for gestational age (322 700)
occurred in South or South East Asia. National level
estimates are shown in appendix 7.
Compared with the US 1991 birth population, the
total number of neonatal deaths attributable to small
for gestational age with the Intergrowth standard
was about 21% lower (appendix 8). There was also
a relatively large reduction (48%) in the number of
neonatal deaths attributed to small for gestational
age in term infants who weighed ≥2500 g as well as
preterm small for gestational age (42%) infants with
the Intergrowth classification, in large part because of
the lower prevalence of births in these groups with the
Intergrowth standard.
Table 3 lists the 10 countries with the largest
numbers of estimated deaths in infants born small for
gestational age in 2012. The highest number was in
India, where 9.1 million such infants (36.5% of live
births) were born in 2012, with 202 300 attributable
neonatal deaths. Pakistan and Nigeria also had high
numbers of both infants born small for gestational
age (1.7 million in Pakistan, 1.1 million in Nigeria)25
and attributable neonatal deaths (53 700 and 51 800,
respectively). The highest proportions of neonatal
deaths that were attributable to small for gestational
age were in Sudan (28.7%), Pakistan (26.5%), and
India (26.0%).
‑In an international, multiethnic setting of optimal
nutrition and health in pregnancy, we would expect
10% of infants to be born small for gestational age.
Reduction in the prevalence of small for gestational

Table 2 | Numbers of 1000s of neonatal deaths in 2012 attributable to term and preterm infants born small for gestational age (SGA) in low and middle
income countries in regions covered by UN Millennium Development Goals
No (UR*) of neonatal deaths (1000s)
Term SGA
No of live
births (1000s)*

Total
(1000s)

Not low birth
weight

Caucasus/Central Asia
Eastern Asia
Latin America/Caribbean
Northern Africa
Oceania
South East Asia
South Asia
Sub-Saharan Africa

1774.3
19 097.2
10 833.3
3989.8
266.4
9691.1
36 625.8
33 727.5

26.5
158.9
105.9
50.6
5.7
143.9
1127.3
1090.2

Western Asia
Total

4844.9
120 850.2

63.4
2772.4

—
—
—
1.6 (0.8 to 2.9)
—
—
—
72.2 (41.7 to
118.3)
—
73.8 (42.5
to 120.7)

Low birth weight

Preterm SGA

All SGA

Population
attributable
fraction† (UR*)

1.5 (0.9 to 2.5)
4.2 (1.9 to 8.3)
8.6 (6.5 to 17.5)
2.7 (1.4 to 5.0)
0.5 (0.3 to 0.8)
14.5 (9.2 to 21.9)
175.8 (123.0 to 248.1)
123.2 (68.7 to 198.5)

2.3 (1.2 to 4.3)
11.9 (6.3 to 21.5)
18.7 (13.1 to 29.6)
0.9 (0.4 to 1.8)
0.4 (0.2 to 0.9)
18.5 (9.5 to 33.4)
113.9 (63.2 to 204.4)
23.9 (11.4 to 47.3)

3.8 (2.6 to 5.8)
16.1 (10.3 to 25.9)
27.3 (24.8 to 40.4)
5.2 (3.1 to 8.8)
0.9 (0.7 to 1.4)
33.0 (24.4 to 47.3)
289.7 (227.6 to 383.1)
219.3 (143.3 to 325.4)

14.3 (9.9 to 22.0)
10.1 (6.5 to 16.3)
25.8 (23.4 to 38.1)
10.3 (6.1 to 17.3)
15.8 (11.4 to 24.0)
22.9 (17.0 to 32.9)
25.7 (20.2 to 34.0)
20.1 (13.1 to 29.8)

5.6 (3.6 to 8.4)
5.4 (2.8 to 10.0)
11.0 (8.2 to 15.5)
17.4 (13.0 to 24.5)
336.8 (250.7 to 453.8) 195.9 (123.0 to 325.0) 606.5 (494.8 to 772.9) 21.9 (17.8 to 27.9)

*Uncertainty range (UR) derived with bootstrap approach (see appendix 4).
†%of neonatal deaths attributable to SGA.

the bmj | BMJ 2017;358:j3677 | doi: 10.1136/bmj.j3677

5

Proportion of neonatal
deaths attributable to SGA

RESEARCH
Preterm SGA
Term SGA, LBW
Term SGA, not LBW

30

20

10

La

tin

Am

Ea

Ce
nt

ra
lA
si
st
er a
er
n
ic
As
a/
Ca
ia
No rib
rth bea
n
er
n
Af
ric
a
So Oc
ea
ut
n
h
Ea ia
st
As
Su
So
ia
but
Sa
h
As
ha
ia
ra
n
A
W
f
r
ic
es
a
te
rn
As
ia

0

Fig 4 | Proportion of total neonatal deaths attributable
to infants born small for gestational age (SGA) in low
and middle income countries in 2012 by UN-MDG region.
LBW=low birth weight (<2500 g)

age from 19.3% to 10.0% in low and middle income
countries could reduce total neonatal deaths by
9.2% (254 600 neonatal deaths; uncertainty range
164 800 to 449 700, appendix 9). The highest impact
on newborn lives saved would be seen in India
(n=109 000), Pakistan (27 000), Nigeria (21 000), and
Ethiopia (21 000).

Discussion
Our study reports the first global estimates of the
burden of small for gestational age among live births
and the contribution of small for gestational age as a
risk factor for (or indirect cause of) neonatal mortality
with the Intergrowth standard, for the year 2012. We
estimate that in low and middle income countries, 23.3
million infants (19.3%) were born small for gestational
age (11.2 million term and not low birth weight,
10.7 million term and low birth weight, 1.5 million
preterm), and about 606 500 neonatal deaths (21.9%)
were attributable to being born small for gestational
age. The highest burden was in South Asia, where up
to 34% of infants might be born small for gestational
age and 26% of neonatal deaths were attributable to
small for gestational age. If the prevalence of small

for gestational age were reduced to a level of 10% (the
prevalence that would be expected in an international
population of optimal nutrition and health in
pregnancy) in all low and middle income countries, an
estimated 9.2% of neonatal deaths (n=254 600) could
be averted.
In this analysis, we used the Intergrowth standard
to classify small for gestational age infants2150 because
our primary objective was to determine the global
burden of suboptimal fetal growth, aspiring to a
scenario where all mothers’ nutritional and health
needs are met. There is still extensive debate, however,
about the use of a single universal standard versus
ethnic specific or customized fetal growth standards,
and whether Intergrowth’s population was too
selective. While genetic potential for growth can differ
across populations, we think that in low and middle
income countries these differences play a smaller
role compared with the much larger variability in
maternal nutritional status and health in pregnancy.5
Intergrowth showed in their cohort (n=20 486) that
fetuses in healthy well nourished pregnant women
from eight different geographic regions grew similarly
across diverse geographic regions.21 22 Furthermore,
the neonatal birth weights of Intergrowth are
comparable with the WHO Child Growth Standards for
term neonates.21 We therefore chose the Intergrowth
standard as the most appropriate prescriptive standard
to describe the global burden of suboptimal fetal
growth and the population impact of public health
interventions to deal with this.
There is also an argument, however, for the use
of ethnic specific fetal growth references. In the
Netherlands, Visser and colleagues published
population birth weight reference curves and showed
that Dutch Hindustani babies were systematically of
lower birth weight than other ethnic groups, up to 300
g at certain gestational weeks.51 Two recent studies
that used longitudinal ultrasound data in populations
at low obstetric risk have shown ethnic differences in
fetal growth, as measured by ultrasound estimated
fetal weight.1920 The NICHD Fetal Growth study in the
US included women at low obstetric risk and found
significant differences in estimated fetal weight after
20 weeks, with lower weight among Hispanic, Asian,
and Black women compared with non-Hispanic white

Table 3 | Ten countries with highest burden of neonatal mortality attributable to infants born small for gestational age (SGA)

1 India
2 Pakistan
3 Nigeria
4 Bangladesh
5 China
6 Indonesia
7 Ethiopia
8 Philippines
9 DR Congo
10 Sudan

No of live
births (1000s)

Neonatal mortality
rate* 2012

Preterm birth
rate 2012 (%)

Prevalence of
SGA (%)

No of attributable neonatal deaths (1000s)
Term SGA

Preterm SGA

All SGA

Population attributable
fraction†

25 000
4800
6800
3100
19 000
4800
3000
2300
2700
1200

30.9
42.2
39.2
24.4
8.5
15.0
29.0
14.0
43.5
28.6

13.1
15.8
12.2
14.1
6.9
15.6
10.2
14.9
12.0
13.4

36.5
36.0
15.6
30.5
4.6
18.0
21.4
25.6
14.5
28.0

126.3
30.8
45.8
10.3
3.8
5.7
20.8
3.6
19.0
9.3

76
22.9
6.0
8.1
11.3
8.8
1.6
3.7
2.6
0.7

202.3
53.7
51.8
18.3
15.1
14.5
22.4
7.3
21.7
10.0

26.0
26.5
19.4
24.2
9.6
19.9
25.5
22.7
18.3
28.7

*Per 1000 live births.
†% of neonatal deaths attributable to SGA.
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women.19 The WHO multinational longitudinal study
of ultrasound biometric measurements and estimated
fetal weight included low risk pregnancies from 10
countries, and reported significant differences in
estimated fetal weight and birth weight between
countries, with the lowest median birth weight in
India.20 There are differences that could explain
the discrepant findings between these studies and
Intergrowth. Intergrowth had stricter nutritional
criteria such as excluding mothers with height <153 cm,
whereas the NICHD and WHO did not exclude mothers
based on height. These latter studies were also of
smaller sample size, were primarily based on estimated
fetal weight by ultrasound, and have not yet published
birth weight standards. The use of individual level,
customized birth weight standards that account for
ethnicity and maternal characteristics (height, weight,
parity) more accurately identified small for gestational
age infants at risk of stillbirth or neonatal mortality in
New Zealand.52 The application of customized charts,
however, is not possible for population level estimates,
and such charts also include targetable risk factors for
small for gestational age in their growth predictions
(for example, maternal undernutrition).
National or ethnic references are also often
challenged by the fact that they are developed from
the local population and are unselected, including
all the pregnancies and existing morbidities of a local
population/catchment area. Though these describe
local patterns of fetal growth, they also include
pregnancies that are affected by undernutrition and
morbidities such as infections (for example, malaria,
syphilis) and hypertension. Therefore, small for
gestational age simply defines the lowest 10% of these
populations, but this classification does not identify
the many more newborns affected by poor growth.
Use of local curves results in a predefined prevalence
of small for gestational age close to 10%, irrespective
of a population’s health and nutritional status.
For example, with the Bhatia reference that was
developed for single liveborn infants in India,53 the
estimated number of infants born small for gestational
age in South Asia for 2012 would be reduced to 3.8
million infants (10.5% of live births) in the year
2012,17 compared with 12.5 million (34%) with the
Intergrowth standard.
Intergrowth’s 10th centile birth weight cutoff was
generally 150-200 g lower across gestational weeks
compared with the commonly cited US national
reference population. For example, for boys born after
37 completed gestational weeks, the 10th centile was
2380 g (Intergrowth) versus 2596 g (US reference
population).54 Use of the Intergrowth standard
reduced the numbers of infants classified as small for
gestational age by a relative 27% overall compared
with the US 1991 reference, particularly term infants
weighing ≥2500 g and late preterm (33-37 weeks).
With a lower birth weight cut off, the Intergrowth
standard identified a higher risk population.
The co-occurrence of prematurity and small for
gestational age places infants at substantially, and
the bmj | BMJ 2017;358:j3677 | doi: 10.1136/bmj.j3677

potentially synergistically, higher risk of morbidity
and neonatal mortality54 compared with their
counterparts who experience prematurity or small
for gestational age alone. Each year, an estimated
1.5 million infants are born both preterm and small
for gestational age, and these small high risk infants
are a top priority for public health interventions. The
estimates related to infants born both preterm and
small for gestational age were the most affected by
the choice of growth standard. Prior population birth
weight references, such as the US reference used in our
study, have included all pregnancies. In comparison,
the Intergrowth study excluded pregnancies in women
with morbidities, meaning that preterm births caused
by common maternal morbidities in US populations,
such as obesity and gestational diabetes, were
removed from the study population. This resulted in
fewer preterm births and the captured preterm births
represented a healthier subset. The Intergrowth
standard had lower 10th centile birth weight cut offs,
more so for lower gestational ages, thus our estimates
for small for gestational age among preterm births
were 47% lower with the Intergrowth standard than
with the US reference.8
The primary prevention of intrauterine growth
restriction in low and middle income countries is
an important intervention target, particularly in
South Asia, where prevalence is high. The causes
of intrauterine growth restriction vary by setting.
While nutritional deficiency is expected to be the
largest contributor in low and middle income
countries, there are other causal mechanisms, such
as maternal infections, placental insufficiency,
pregnancy morbidity, and environmental exposures
that contribute in these settings. Further research
on the country or region specific epidemiology
and appropriate context specific solutions will be
necessary to deal with primary prevention effectively.
A more immediate goal is targeting the coverage and
quality of interventions to manage morbidities of
infants born small for gestational age, which will
also benefit preterm infants. An estimated 80% of
neonatal deaths occur in infants of small size (small for
gestational age and/or preterm).41 Small for gestational
age infants have an increased risk of perinatal
respiratory depression55 from chronic uteroplacental
insufficiency56 and postnatal infections from retarded
development of the immune system.57 Interventions
such as neonatal resuscitation, management of sepsis,
chlorhexidine antisepsis of the umbilical cord, and
early breastfeeding support could successfully target
the reduction in mortality associated with small for
gestational age. The effect of kangaroo mother care
in term infants born small for gestational age also
deserves further evaluation.

Limitations
The CHERG datasets had several limitations. Several
of the cohorts were community based studies with
some missing birth weight data; however, we included
only datasets with limited amounts of missing data
7
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and weight measured within 72 hours of birth, using
strict a priori inclusion criteria reported elsewhere.8
Also, data were available only from select countries
within regions and thus might not be representative
of the entire region. We therefore used pooled regional
risk ratios, aiming to increase generalizability of
the estimations, and national level prevalence and
mortality rates. Concerted efforts are needed to improve
the coverage and quality of birth weight data in low and
middle income countries, particularly in South Asia
and sub-Saharan Africa, where over half of infants are
never weighed at birth.58 Another limitation was the
heterogeneity and quality of measures of gestational
age. Ultrasound measures were not available in most
studies, and the remaining studies used date of last
menstrual period or clinical newborn assessment.
Three studies, in which date of last menstrual period
was collected during routine pregnancy surveillance,
are likely to be more accurate.59 Dating of gestational
age remains a large obstacle for research and
programmatic projects in low and middle income
countries. Accurate and feasible methods of gestational
age dating will be necessary in the future in these
countries to improve our epidemiologic understanding
of the burden of preterm birth and small for gestational
age. Finally, our analyses only represented the burden
of SGA among live born babies. Intrauterine growth
restriction is an important cause of stillbirth, and not
represented in this analysis.

Conclusions
We estimated that 23.3 million infants (19.3%) were
born small for gestational age and 606 500 (21.9%)
neonatal deaths were attributable to small for
gestational age in low and middle income countries
in 2012. The largest burden was in South Asia, where
34% of infants were born small for gestational age and
289 700 neonatal deaths were attributable to small
for gestational age. Beyond the neonatal period, small
for gestational age infants are at increased risk of
experiencing later morbidity in childhood, including
poor linear growth and chronic non-communicable
disease in adulthood, a large yet unquantified burden.
Overcoming implementation barriers and increasing
coverage of proved interventions to prevent fetal
growth restriction and improve survival of small
infants are key priorities to reduce neonatal mortality
in low and middle income countries.
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